
Prolocor
Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredFeb 17, 2020 (6 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Companies like Prolocor
BBiotia$9M Series A · Oct 2026
AAxio$23M Series B+ · Aug 2022
BBioCardia$4.4M · Jun 2026
AArnatar Therapeutics$50M Series A · Mar 2026
CCardurion Pharmaceuticals$260M Series B+ · Jul 2024
VVasa TherapeuticsSeed · Jan 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/prolocor (get a free API key).